Related Experiment Video
Updated: Mar 26, 2026

08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
7.4K
Non-neoplastic Pathology in Tumor Nephrectomy Specimens.
1Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.
Surgical Pathology Clinics
|February 4, 2016
Summary
Analyzing non-cancerous kidney tissue in surgical specimens can identify patients at risk for chronic kidney disease (CKD) progression after kidney cancer surgery. Early identification aids intervention, potentially improving outcomes for these patients.
Area of Science:
- Nephrology
- Oncology
- Pathology
Background:
- Kidney cancer (renal cell carcinoma) and chronic kidney disease (CKD) share similar risk factors.
- A significant percentage of patients undergoing nephrectomy for renal cell carcinoma have pre-existing CKD or develop it post-surgery.
- Current methods may not fully identify all at-risk patients before or after surgery.
Purpose of the Study:
- To determine if examining non-neoplastic kidney tissue in nephrectomy specimens can predict CKD progression.
- To identify patients who may benefit from early intervention to mitigate CKD development or worsening.
Main Methods:
- Histopathological evaluation of non-neoplastic parenchyma within renal cell carcinoma nephrectomy specimens.
- Correlation of pathological findings with pre- and post-operative renal function markers.
- Analysis of patient data to identify predictors of CKD progression.
Main Results:
- Non-neoplastic kidney tissue analysis can identify patients at higher risk for developing or progressing in CKD post-nephrectomy.
- Specific pathological features in the non-tumorous kidney tissue are associated with poorer renal function outcomes.
- This evaluation provides a window into future kidney health for renal cell carcinoma patients.
Conclusions:
- Examining non-tumorous kidney tissue in surgical specimens is a valuable tool for risk stratification of CKD progression.
- This approach allows for proactive management strategies in renal cell carcinoma patients at risk of kidney disease.
- Early identification and intervention can potentially reduce morbidity and mortality associated with CKD in this population.

